Episode 6

Samir Ounzain, HAYA Therapeutics

Published on: 6th November, 2025

How do you lead a company across continents and through uncertainty?

In this episode of A Call to Lead, David Kirk speaks with Samir Ounzain, CEO and scientific co-founder of Haya Therapeutics.

Samir shares how a lifelong curiosity about how cells “speak” to their environment led him from academia to building a company at the frontier of RNA-guided medicine.

He reflects on what it takes to lead through uncertainty, translate visionary science into tangible therapies, and build culture and alignment across continents. This conversation is a masterclass in marrying deep biology with purposeful leadership.

Next Episode All Episodes Previous Episode

Listen for free

Show artwork for A Call to Lead @LifeScience ORG

About the Podcast

A Call to Lead @LifeScience ORG
Sharing the leadership journeys of life science entrepreneurs shaping the future of healthcare.
A Call To Lead is a series shining a light on the leadership, vision, and impact of European life science CEOs who are proving that world-class ventures don’t need to be built in Boston to shape the future of healthcare.

Each episode features a one-on-one conversation with a European life science CEO and member of the LifeScience ORG community. Our conversations are not about companies or pipelines; instead, guests reflect on their personal journeys, the pivotal choices that shaped their careers, and the future they are helping to build. These kinds of insights are rarely shared publicly.

New episodes are released every Thursday.